NMR studies of the inclusion complex between β-cyclodextrin and paroxetine

被引:42
作者
Bernini, A
Spiga, O
Ciutti, A
Scarselli, M
Bottoni, G
Mascagni, P
Niccolai, N
机构
[1] Univ Siena, Biomol Struct Res Ctr, I-53100 Siena, Italy
[2] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy
[3] Italfarmaco Res Ctr, I-20092 Milan, Italy
关键词
paroxetine; cyclodextrin inclusion complex; NMR; molecular modelling;
D O I
10.1016/j.ejps.2004.04.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A H-1 and C-13 NMR study on the inclusion complex of paroxetine with beta-cyclodextrin was carried out in order to define the stoichiornetry of the association and its strength. Proton and carbon chemical shift measurements of paroxetine and beta-cyclodextrin were performed a, several molar ratios and temperatures, allowing the determination of a 1:1 stoichiometry and an association constant value of the order of 2 x 10(3) for the paroxetine-beta-cyclodextrin complex. Overhauser effects in the rotating frame were also measured, and the experimental interproton distance constraints have been used for molecular model building of the complex. The obtained model indicates that the benzodioxolyl moiety of paroxetine is deeply inserted in the cavity of the cylindrical structure of p-cyclodextrin, while the fluoro-phenyl ring lays above the wider rim. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:445 / 450
页数:6
相关论文
共 14 条
[1]   Synthesis of enantiopure 3,4-disubstituted piperidines. An asymmetric synthesis of (+)-paroxetine [J].
Amat, M ;
Hidalgo, J ;
Bosch, J .
TETRAHEDRON-ASYMMETRY, 1996, 7 (06) :1591-1594
[2]  
Andersen B, 1990, J AFFECT DISORDERS, V18, P289
[3]   HIGH-FIELD NUCLEAR-MAGNETIC-RESONANCE TECHNIQUES FOR THE INVESTIGATION OF A BETA-CYCLODEXTRIN-INDOMETHACIN INCLUSION COMPLEX [J].
DJEDAINI, F ;
LIN, SZ ;
PERLY, B ;
WOUESSIDJEWE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (07) :643-646
[4]   H-1 NMR and molecular modeling study on the inclusion complex beta-cyclodextrin indomethacin [J].
Fronza, G ;
Mele, A ;
Redenti, E ;
Ventura, P .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (03) :909-914
[5]   BINDING MECHANISMS IN CYCLOHEXAAMYLOSE COMPLEXES [J].
GELB, RI ;
SCHWARTZ, LM ;
CARDELINO, B ;
FUHRMAN, HS ;
JOHNSON, RF ;
LAUFER, DA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1981, 103 (07) :1750-1757
[6]   GEOMETRY OF CYCLOHEXAAMYLOSE INCLUSION COMPLEXES WITH SOME SUBSTITUTED BENZENES IN AQUEOUS-SOLUTION BASED ON C-13 NMR CHEMICAL-SHIFTS [J].
INOUE, Y ;
HOSHI, H ;
SAKURAI, M ;
CHUJO, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (08) :2319-2323
[7]  
Inoue Y., 1993, Annual Reports on NMR Spectroscopy, VVolume 27, P59, DOI DOI 10.1016/S0066-4103(08)60265-3
[8]  
Job P, 1928, ANN CHIM FRANCE, V9, P113
[9]   Measurement of molecular association in drug:cyclodextrin inclusion complexes with improved H-1 NMR studies [J].
Loukas, YL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (10) :944-948
[10]  
MASCAGNI P, 1999, Patent No. 0102393